Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

FitRx vs Kin Meds

FitRx
Graded #196

Lower grade

vs+6.700000000000003
Kin Meds
Graded #73

Higher grade

The verdict

Kin Meds takes it — 72.9/100 to 66.2/100.

Kin Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Kin Meds is a LegitScript-verified telehealth platform offering both compounded GLP-1s (semaglutide from $199/mo, tirzepatide from $249/mo) and brand-name FDA-approved options including Wegovy injection and…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueKin Meds +11
63
74
Dose & formulationKin Meds +28
65
93
Clinical oversightFitRx +2
76
74
Labs & monitoringEven
53
53
FulfillmentFitRx +16
88
72
Contract termsKin Meds +8
47
55
FitRx · left barKin Meds · right bar

The numbers

MetricFitRxKin Meds
WeighScore66.2/10072.9/100
GradeCC
Scorecard rank#196#73
Semaglutide$151/mo (quarterly plan, compounded)$149/mo (brand Wegovy)
TirzepatideNot disclosed$149/mo (brand Zepbound)
CoverageAll 50 statesCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
FitRx

Graded #196 · C

Strengths

  • Insurance coordination for brand-name GLP-1s — as low as $25/mo
  • All four major brand-name GLP-1s available (Ozempic, Wegovy, Zepbound, Mounjaro)
  • LegitScript certified
  • All 50 states + DC coverage
  • Compounded semaglutide from $151/mo quarterly for uninsured patients

Where it loses points

  • Insurance coordination may not work for all plans
  • Broader platform (birth control, mental health, hair loss, ED, skincare, primary care)
  • Compounded option is semaglutide only — no compounded tirzepatide
Kin Meds

Graded #73 · C

Strengths

  • Publicly lists $199/mo compounded semaglutide and $249/mo compounded tirzepatide
  • Brand-name options too — Wegovy injection and pill, Zepbound, Foundayo from $149/mo entry pricing
  • LegitScript verified
  • Clearly identifies itself as the intake platform and a licensed third-party pharmacy as the dispenser
  • Broad longevity menu (Sermorelin, NAD+, Glutathione) plus TRT, hair, skin, and sexual health

Where it loses points

  • Legal entity name and state of incorporation not publicly disclosed
  • The third-party pharmacy partner isn't named, and Kin Meds isn't itself a licensed pharmacy
  • Per-state availability not listed
  • $149/mo brand pricing is the insured entry tier — cash-pay patients should expect higher real costs
  • Lab work and dose-titration support not clearly described

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard